{"text": ["Roche", "buys", "U.S.", "biotech", "Jecure", "in", "race", "for", "liver", "disease", "drugs"], "created_at": "2018-11-27 18:41:58"}
{"text": ["Novartis's", "Alcon", "sees", "myopia", "epidemic", "driving", "sales", "growth"], "created_at": "2018-11-27 17:25:02"}
{"text": ["3", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "is", "Up", "This", "Year", "So", "Far"], "created_at": "2018-11-27 17:07:47"}
{"text": ["3", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "is", "Up", "This", "Year", "So", "Far"], "created_at": "2018-11-27 17:07:47"}
{"text": ["3", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "is", "Up", "This", "Year", "So", "Far"], "created_at": "2018-11-27 15:34:03"}
{"text": ["Alcon", "To", "Highlight", "Vision,", "Strategy,", "Benefits", "As", "Standalone", "Company", "Post", "Spinoff"], "created_at": "2018-11-27 01:28:00"}
{"text": ["Alcon", "To", "Highlight", "Vision,", "Strategy,", "Benefits", "As", "Standalone", "Company", "Post", "Spinoff"], "created_at": "2018-11-27 01:28:00"}
